Content Type: Article

  • LSTA Publishes Revised Secondary Trading Documents

    LSTA Publishes Revised Secondary Trading Documents

    ARTICLE / CLIENT ALERT

    LSTA Publishes Revised Secondary Trading Documents

    June 13, 2017

    Read time: 4 min

    Key takeaways
    Overview

    The Loan Syndications and Trading Association (“LSTA”) published revised secondary trading documents on June 9, 2017. The revised documents will apply to trades with a trade date on or after June 9, 2017. The most significant changes that have been incorporated in all documents are highlighted below:

    • The “Paid on Settlement Date” interest convention has been revised to include a clawback right of the buyer. “Paid on Settlement Date” previously provided that all interest paid by the borrower up until the Settlement Date was for the benefit of seller and an amount equal to the accrued but unpaid amount of such interest up until the Settlement Date (“POSD Amount”) would be paid by buyer to seller. If the borrower then paid the POSD Amount to buyer, buyer would keep that amount. If such amount was paid to seller, seller would pay the amount to buyer. If, however, the borrower later failed to pay the POSD Amount on or prior to the scheduled due date (taking into account any applicable grace period) in accordance with the credit documentation or any adequate protection order, seller would not be required to reimburse buyer for such amount. The LSTA has now revised the standard terms and conditions to allow buyer to clawback any amounts it has paid to seller if the borrower later fails to pay.
    • “Non-Recurring Fees” are now defined as amendment, consent, waiver and other similar non-ordinary course fees that are payable in connection with the Purchase Amount of the Debt pursuant to the Credit Documents from and after the Trade Date, and any other amounts payable in connection with the Purchase Amount of the Debt pursuant to the Credit Documents from and after the Trade Date not constituting Interest and Accruing Fees or PIK Interest.
    • The Interest Payments and Fees section of the Par Confirmation Standard Terms and Conditions (Section 5) now includes “Adequate Protection Payments” (if applicable) in addition to “Interest and Accruing Fees” and the interest convention shall apply to both.
    • The LSTA has included language in its revised documents in light of the new DOL ERISA Fiduciary Regulation that took effect on June 9, 2017. The DOL regulation is expanding the definition of who is a fiduciary in the context of marketing investment products to individual retirement accounts and ERISA-covered pension plans. For more information about the new rule, please see the SRZ Alert “New DOL ERISA Fiduciary Regulation Takes Effect (at Least for Now) ” (June 2, 2017).
    • The previously inconsistent references to “Credit Agreement” and “Credit Documents” across the trading documents have now been replaced with the term “Credit Documents.”

    The defined term “Federal Funds Rate” has been amended to reflect the Federal Reserve Bank of New York changes to the calculation of the federal funds effective rate.


    Authored by David J. Karp and Alexia Petrou.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.

    In depth
    Authors
    More insights

  • Organists Guild Brought Up Short by FTC

    ARTICLE

    Organists Guild Brought Up Short by FTC

    June 13, 2017

    Read time: 2 min

    Key takeaways
    Overview

    Katharine O’Connor and Gregory Heltzer wrote, in an Antitrust Alert cited here, that the FTC “will continue to investigate and pursue trade associations and professional guilds for rules and guidelines that encourage or require members to limit competition with one another” Thus, the lawyers concluded, associations and guilds “should be cautious” of any actions by which members “may be seen to be sharing or agreeing to any pricing.”

    In depth
    Authors

    Gregory E. Heltzer

    Partner

    Washington, DC

    More insights

  • FCA Settlement Raises Questions For Health IT Industry

    ARTICLE

    FCA Settlement Raises Questions For Health IT Industry

    June 13, 2017

    Read time: 2 min

    Key takeaways
    Overview

    Daniel Gottlieb, Tony Maida and Joan Polacheck wrote this bylined article about a Justice Department settlement of Fair Claims Act (FCA) allegations that a vendor of electronic health record (EHR) software caused its healthcare provider customers to submit false Medicare and Medicaid claims. The settlement “has sent shockwaves through the health information technology (HIT) industry and may be a sign of increasing FCA actions against vendors of EHR technology,” the authors wrote.

    In depth
    Authors

    Daniel F. Gottlieb

    Partner

    Chicago

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    More insights

  • New DOL Rule: Subscription Document Supplement

    New DOL Rule: Subscription Document Supplement

    ARTICLE / CLIENT ALERT

    New DOL Rule: Subscription Document Supplement

    June 9, 2017

    Read time: 4 min

    Key takeaways
    Overview

    The DOL regulation expanding the definition of who is a fiduciary in the context of marketing investment products to Individual Retirement Accounts (“IRAs”) and ERISA-covered pension plans (“ERISA Plans”) takes effect on June 9. In our Alert of June 2, we noted that in an op-ed piece, Secretary of Labor Acosta expressed concern about the rule and the limitation it placed on an individual’s freedom of choice. On Monday, SEC Chairman Clayton indicated that the SEC wants to work with the DOL in shaping a revised rule, and on Wednesday, Secretary Acosta, testifying before a subcommittee of the House Appropriations Committee, discussed the DOL’s request for feedback from stakeholders published in the Federal Register. Secretary Acosta indicated that, in reviewing the new regulation, the DOL would listen to the concerns that “were not heard” by the Obama administration.

    An example of a subscription document supplement is available here for IRA and ERISA Plan investors subscribing for interests in funds or subscribing to make an additional investment in funds after June 9. (Please note that capital calls issued in respect of subscriptions accepted prior to June 9 are not additional investments for this purpose.) It may be advisable to use a supplement rather than modifying existing subscription agreements given the uncertainty regarding the rule going forward. The supplement is similar in scope to the sample letter that we sent last week and is intended to help firms establish a reasonable belief that one of the carve outs to the new rule will not cause the investment adviser of the fund to be a fiduciary to the IRA and ERISA Plans in connection with marketing activities. The distinction between the sample letter and the supplement to the subscription agreement is that the supplement requires an investor that has checked the box that it is a benefit plan investor to represent that it either is advised by a consultant in making its investment decision or that the individuals who make that decision for an ERISA Plan manage at least $50 million in assets. The supplement is intended to be used in place of the sample letter for investors making new and/or add-on investments.

    If a potential investor cannot answer yes to one of the five choices (or in the case of an IRA or self-directed 401(k) Plan cannot answer yes to one of the first four choices), you should consider rejecting the investment to ensure that the investment adviser to the fund will not become a fiduciary to the potential investor in connection with their investment decision.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel.


    This information has been prepared by Schulte Roth & Zabel LLP (“SRZ”) for general informational purposes only. It does not constitute legal advice, and is presented without any representation or warranty as to its accuracy, completeness or timeliness. Transmission or receipt of this information does not create an attorney-client relationship with SRZ. Electronic mail or other communications with SRZ cannot be guaranteed to be confidential and will not (without SRZ agreement) create an attorney-client relationship with SRZ. Parties seeking advice should consult with legal counsel familiar with their particular circumstances. The contents of these materials may constitute attorney advertising under the regulations of various jurisdictions.

    In depth
    Authors
    More insights

  • Subpart F: Gain on the Sale of a Business

    ARTICLE

    Subpart F: Gain on the Sale of a Business

    June 9, 2017

    Read time: 2 min

    Key takeaways
    Overview

    Lowell Yoder wrote this bylined article describing controlled foreign corporation (CFC) sale of foreign business to a related CFC in a taxable transaction. “As a general rule, gain on the sale of property used in the CFC’s business should not be FPHCI (foreign personal holding company income) but gain with respect to passive assets can be FPHCI, and under limited circumstances gain that is not FPHCI can be foreign base company sales income,” Mr. Yoder wrote.

    In depth
    Authors

    Lowell D. Yoder

    Partner

    Chicago

    More insights

  • Proposed Changes to § 409a Regulations: Greater Clarity and Better Planning Alternatives

    ARTICLE

    Proposed Changes to § 409a Regulations: Greater Clarity and Better Planning Alternatives

    Spring 2017

    Read time: 2 min

    Key takeaways
    Overview

    Andrew Liazos and Allison Wilkerson wrote this bylined article on Tax Code Section 409A’s deferral and payment requirements for nonqualified deferred com­pensation plans. Recent IRS Section 409A guidance makes “several helpful changes that employers will want to consider and take advantage of,” the authors wrote, and they warned employers that they ignore final IRS “at their peril…in light of the more limited ability to correct errors.”

    In depth
    Authors

    Andrew C. Liazos

    Partner

    Boston, New York – One Vanderbilt Avenue

    Allison Wilkerson

    Partner

    Dallas

    More insights

  • Inside SALT: Significant State Tax Developments and Opportunities

    Inside SALT: Significant State Tax Developments and Opportunities

    ARTICLE

    Inside SALT: Significant State Tax Developments and Opportunities

    June 8, 2017

    Read time: 2 min

    Key takeaways
    Overview

    View Map

    Time

    8:30 – 9:30 am EDT — Breakfast and Registration

    9:00 – 11:30 am EDT — Program

    11:30 am – 12:30 pm EDT — Lunch and Roundtable Discussion

    Venue

    McDermott Will & Emery

    340 Madison Avenue

    New York, NY 10173

    Please join us for an informative half-day program presented by lawyers in McDermott Will & Emery’s State and Local Tax Group. A wide range of topics will be discussed, including

    • New York developments, including false claims and budget provisions
    • Nexus updates and developments in digital taxation
    • New developments in apportionment, transfer pricing developments and unclaimed property

    For more information, please contact Esther Stone.

    CLE credit is pending in California, Illinois, New York and Texas. A Uniform Certificate of Attendance will be made available to participants requesting CLE credit in all other states. CPE credit is pending in Illinois and California. A Uniform Certificate of Completion will be made available to participants requesting CPE credit in all other states.

    In depth
    Authors

    Catherine A. Battin

    Partner

    Chicago

    Todd Harrison

    Partner

    New York – One Vanderbilt Avenue

    Stephen P. Kranz

    Partner

    Washington, DC

    Arthur R. Rosen

    Senior Counsel

    Miami, New York – One Vanderbilt Avenue

    More insights

  • False Claims Act Settlement with eClinicalWorks Raises Questions for Electronic Health Record Software Vendors

    False Claims Act Settlement with eClinicalWorks Raises Questions for Electronic Health Record Software Vendors

    ARTICLE / CLIENT ALERT

    False Claims Act Settlement with eClinicalWorks Raises Questions for Electronic Health Record Software Vendors

    June 8, 2017

    Read time: 11 min

    Key takeaways
    Overview

    On May 31, 2017, the US Department of Justice announced a Settlement Agreement under which eClinicalWorks, a vendor of electronic health record software, agreed to pay $155 million and enter into a five-year Corporate Integrity Agreement to resolve allegations that it caused its customers to submit false claims for Medicare and Medicaid meaningful use payments in violation of the False Claims Act.

    In depth

    The US Department of Justice (DOJ) announced on May 31, 2017, an agreement (Settlement Agreement) settling allegations in the DOJ’s Complaint-in-Intervention (Complaint) that eClinicalWorks (ECW), a vendor of electronic health record (EHR) software, caused its health care provider customers to submit false Medicare and Medicaid claims for meaningful use payments in violation of the False Claims Act (FCA). Under the Settlement Agreement, ECW agreed to pay approximately $155 million to resolve the allegations without admitting liability and an ECW software developer and two project managers agreed to pay additional amounts. ECW also entered into a five-year Corporate Integrity Agreement (CIA) with strict compliance oversight and reporting obligations and costly obligations to provide the latest version of ECW’s EHR software (including related implementation and training services) to each of ECW’s current customers free of charge.

    The groundbreaking settlement has sent shockwaves through the health information technology (HIT) industry and may be a sign of increasing FCA actions against vendors of EHR technology (CEHRT) certified through the HIT certification program of the Office of the National Coordinator of HIT (ONC). HIT vendors should review, and consider improvements to, their systems and other procedures for identifying, responding to and correcting software design and quality issues that call into question EHR software’s conformity to applicable EHR certification criteria or present patient safety or clinician usability risks. HIT vendors should also review existing customer referral and marketing arrangements compliance with the Anti-Kickback Statute.

    The following sections of this On the Subject discuss the key elements and implications of the Complaint, Settlement Agreement and CIA.

    Allegations

    The DOJ’s Complaint included two categories of allegations. The predominate allegations concerned false statements concerning ECW’s EHR software, but also included certain allegations regarding improper payments (i.e., kickbacks) to referral sources in violation of the Anti-Kickback Statute.

    False Statements
    First, the DOJ (and the whistleblower) allege that ECW made material false statements and concealed material facts from its certifying body about the extent to which ECW’s EHR software met the 2011 Edition and 2014 Edition of the ONC’s EHR certification criteria. For example, according to the Complaint, to pass certification testing related to implementation of the RxNorm standardized drug vocabulary in the EHR software’s e-prescribing functionality, ECW modified its EHR software by hardcoding only the RxNorm standardized drug codes for the 16 drugs tested by the certification body’s publicly available test scripts and not any other drugs.

    The EHR software needed to be certified as CEHRT under the criteria in order for ECW’s physician practice customers to properly achieve meaningful use under the Medicare and Medicaid EHR Incentive Programs, commonly known as the “Meaningful Use Programs.” Physician practices cannot earn incentive payments for using paper medical records or legacy EHR systems that are not CEHRT. By achieving meaningful use of CEHRT, physician practices could receive Medicare EHR Incentive Payments of up to $43,720 per physician or other Medicare eligible professional, or up to $63,750 of Medicaid EHR incentive payments per Medicaid eligible professional.

    In addition, after earning incentive payments, practices could subsequently avoid reimbursement penalties under the Medicare Physician Fee Schedule by achieving meaningful use of CEHRT. However, the Complaint did not address any Medicare reimbursement penalties that were not applied because of providers’ false meaningful use attestation. Currently, physicians participating in Medicare may use CEHRT to avoid reimbursement penalties under the Medicare Merit-Based Incentive Payment System (MIPS) launched this year by the Centers for Medicare and Medicaid Services and other Medicare Quality Payment Programs.

    As a result, the DOJ alleges that ECW caused its customers to receive unearned EHR incentive payments by submitting false attestations of meaningful use of CEHRT. Based on the Complaint, it appears that the DOJ did not pursue ECW’s physician practice customers for the unearned incentive payments, in part, because ECW’s customers “unknowingly” submitted false attestations (reasonably believing that the ECW EHR software was properly certified as reported on the ONC’s website) and the FCA requires the government (or the whistleblower) to establish that false claims were submitted knowingly.

    Kickbacks
    While the Complaint spends over eight pages detailing conduct involving certification of ECW’s EHR software and meaningful use incentive payments to providers, DOJ only spent one page describing certain marketing arrangements for which ECW allegedly kickbacks to influential customers to induce them to recommend ECW’s EHR software in violation of the Anti-Kickback Statute. ECW paid the purported kickbacks through a referral program, site visit program and a reference program.

    According to the Complaint, under the referral program, ECW paid current customers as much as $500 for each provider they referred who executed a contract with ECW with payments to customers totaling almost $144,000. Under the site visit program, ECW paid customers to host prospective customers and payments varied based on the number hosted and whether the hosted prospect licensed ECW’s software. The Complaint stated that under the reference program, ECW paid current customers as much as $250 to serve as references for the ECW software and speak to prospects. The reference fees varied based on number of references spoken to and whether the prospect licensed the ECW software.

    Based on the scant details about the three ECW programs included in the Complaint, it is unclear exactly what DOJ’s objections were to these arrangements. In particular, the site visit and reference programs could be viewed as typical and commercially reasonable marketing arrangements for information technology that involve customers providing actual marketing services in exchange for the payment. In addition, the Complaint seems to indicate that DOJ included the allegations about these programs because they resulted in more customers submitting claims for meaningful use incentive payments related to EHR software that did not meet the certification criteria, which was the main focus of DOJ’s Complaint.

    In addition, the Office of the Inspector General (OIG) of the US Department of Health and Human Services has for years consistently stated that marketing payments technically implicate the Anti-Kickback Statute, but has also recognized that payment for marketing services are commonplace, and in fact, unavoidable without banning marketing activities entirely. Various advisory opinions and other guidance set forth a multi-factored facts-and-circumstances analysis for distinguishing between proper and improper marketing activities outside the Anti-Kickback Statute safe harbors. The analysis examines the nature of the payment, the type of marketing activity (i.e., active or passive), the type of item or service marketed, the intended audience, and the identity of the marketer and his or her relationship with the intended audience. However, the presence or absence of any of these factors does not necessarily mean that an arrangement violates the Anti-Kickback Statute.

    Ongoing CIA Requirements

    In addition to the large monetary settlement payment, ECW agreed to comply with novel requirements in the CIA, which are discussed below, for a five-year term. These significant CIA requirements appear based on modifying the “independent monitor” model typically used in quality of care CIAs.

    Free Upgrades
    The CIA requires ECW to provide, without charge, to current customers the latest version of the ECW EHR software that includes software updates that correct noncompliance with EHR certification criteria and the latest updates to any drug database supported by the EHR software used by the customer without charge. ECW is also not permitted to charge for implementation and training services for the updated version.

    Free Data Transfer
    The CIA requires ECW to transfer an existing customer’s data without penalties or service charges to the customer or the customer’s designated successor vendor.

    Corporate Compliance Program
    Like CIAs required as part of other FCA settlement agreements, the CIA with ECW requires ECW to implement an effective corporate compliance program that includes a full-time compliance officer, compliance committee, code of conduct, written compliance policies and procedures, a training program and a compliance hotline or other disclosure program.

    The written policies must address a wide range of topics, including, without limitation: compliance with EHR certification criteria and other federal health care program requirements applicable to HIT; compliance with the Anti-Kickback Statutes; software standards and practices (which are discussed below); development and implementation of software modifications to address patient safety issues; adhering to “all applicable aspects of the ONC Safety Assurance Factors for EHR Resilience (SAFER) guides;” staffing of an EHR usability team to address screen and workflow design and other EHR usability issues, an EHR patient safety team and an EHR certification compliance team; and notifying customers of patient safety and certification issues.

    Quality Assurance Program with Software Standards and Practices
    The CIA requires the compliance program to include a quality assurance program with software standards and practices, which are “professionally recognized software development, quality assurance, and risk management standards and practices appropriate to the nature and purposes of EHR systems (including supporting clinical decision-making and the provision of medical care to patients).” As part of the quality assurance program, ECW must proactively monitor information about potential software defects, usability problems and other issues that may present patient safety or EHR certification issues.

    Health Care Provider Payment Sunshine
    The CIA requires ECW to post on its website reports of the cumulative value of payments by ECW to health care providers after the effective date of the CIA.

    Retention of SQOO
    The CIA requires ECW to engage an independent Software Quality Oversight Organization (SQOO) to develop the software standards and practices in consultation with ECW and assess the “effectiveness, reliability and thoroughness of” ECW’s: internal quality control systems designed to address patient safety, certification, usability and other EHR issues; policies, procedures and practices for addressing EHR issues; adherence to software standards and practices and other requirements; other quality assurance program requirements of the CIA; and policies, procedures and practices to ensure that ECW customers are notified of their rights under the CIA. In contrast to OIG’s past approach in selecting the “independent monitor,” here, ECW is required to “seek input” from OIG on selecting an appropriately qualified SQOO within 60 days. If ECW is unable to retain an SQOO that OIG approves of within this time, OIG will select the SQOO.

    Retention of Independent Review Organization
    ECW must retain an independent review organization (IRO) to conduct an arrangements review, which includes a review of (1) ECW’s systems, processes, policies and procedures relating to arrangements involving the offer, payment, solicitation or receipt of anything of value between ECW and any actual or potential source of health care business or referrals (Systems Review) and (2) a review of 50 randomly selected “Focus Arrangements,” which are arrangements between eCW and any actual source of health care business or referrals to eCW that involves, directly or indirectly, the offer, payment or provision of anything of value (Transactions Review). As part of the Transactions Review, the IRO will assess whether ECW has complied with certain procedures and other requirements of the CIA for Focus Arrangements.

    Implications for HIT Vendors

    The settlement amount and extensive CIA requirements provide a clear signal that CEHRT vendors may experience increased scrutiny by the government, as well as whistleblowers, for compliance with the EHR certification criteria because CEHRT may enable health care providers to earn incentive payments or other enhanced reimbursement (or avoid decreased reimbursement) under federal health care programs. The CIA makes clear that the government is not only concerned about improper reimbursement to health care providers, but also patient safety issues caused by defective software and poor usability as well as kickbacks to referral sources. Vendors should consider the following responsive steps:

    • Development and implementation of a compliance program that reflects the elements of an effective corporate compliance program set forth in DOJ and OIG compliance program guidance for the health care industry;
    • Development and implementation of policies, procedures and practices for addressing EHR certification criteria, patient safety and EHR usability considerations into the ongoing software development and design process;
    • Development and implementation of procedures for employees, customers and other persons to report patient safety, usability and compliance issues to vendor management and procedures for promptly tracking, monitoring and resolving the issues;Identification, review and prompt resolution of any currently known or suspected EHR certification criteria compliance issues and patient safety issues;
    • Evaluation of current showcase or reference site arrangements, referral arrangements and other marketing arrangements outside the Anti-Kickback Statute safe harbors with persons in a position to generate new customers and new business to determine whether they reasonably comply with OIG guidance regarding marketing arrangements;
    • Development and implementation of policies, procedures and practices for complying with the Anti-Kickback Statute, including policies for evaluating whether marketing arrangements with referral sources comply with the Anti-Kickback Statute; and
    • Implementation of a comprehensive training program to address the range of health care regulatory compliance matters addressed by the CIA and foster a culture of health care regulatory compliance.

     

    Authors

    Daniel F. Gottlieb

    Partner

    Chicago

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    More insights

  • Florida Earn-Outs: Dealmakers Beware

    ARTICLE

    Florida Earn-Outs: Dealmakers Beware

    June 2017

    Read time: 2 min

    Key takeaways
    Overview

    Asra Chatham co-authored this bylined article on the use of earn-out provisions to resolve buyer-seller disagreements over how much a business is worth. “Foresight, attention to detail, and precision are key” to making earn-out provisions work, the authors wrote, which requires that “the parties identify their expectations in writing and with specificity.”

    In depth
    Authors

    Asra A. Chatham

    Partner

    Miami

    More insights

  • Invalidity of a Subordination Agreement (Rangrücktritt) in General Terms and Conditions

    ARTICLE

    Invalidity of a Subordination Agreement (Rangrücktritt) in General Terms and Conditions

    June 2017

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors
    More insights